Form 8-K Filing - Q32 Bio Inc.

This Form 8-K filing reports a change regarding the Board of Directors for Q32 Bio Inc. Mark Iwicki had initially intended to resign from the Board of Directors, effective December 31, 2025, to reduce his board commitments and focus on his CEO role at Inhibikase Therapeutics, Inc. However, on December 17, 2025, Mr. Iwicki withdrew his resignation with the full support of the Board. He will continue to serve as Chair of the Board and the Compensation Committee, and as a member of the Audit Committee. This decision was made following a reduction in the number of boards Mr. Iwicki serves on.